Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Pine Pharmaceuticals, LLC to request your refund or repair — edit it as you like.
Subject: Recall D-0582-2016 — Pine Pharmaceuticals, LLC Pine Pharmaceuticals, LLC recalls Bevacizumab 1.25 mg/0.05 mL filled to 0 Hello, I own a Pine Pharmaceuticals, LLC recalls Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine that is covered by recall D-0582-2016 from Pine Pharmaceuticals, LLC. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
